Atrial fibrillation (AFib) is the most common abnormal heart rhythm and affects 2.7 to 6.1 million people in the U.S. and studies suggest that the incidence and prevalence is increasing (CDC, 2020). AFib is associated with a fivefold increase in the risk of ischemic stroke. In fact, 1 in 7 strokes are caused by AFib (CDC, 2020). Several guidelines recommend patients with AFib NOT identified as “low risk” for stroke be offered anticoagulation therapy. However, these medications are associated with an increased risk for bleeding. Thus, several factors must be considered when determining the most appropriate therapy and modifiable risk factors should be treated before initiating treatment.
The goal of this course is to educate nursing professionals, pharmacists, and providers on therapies for stroke prevention in atrial fibrillation.
Certificates provided by accrediting body (4 Match)
American Nurses Credentialing Center
In support of improving patient care, Relias LLC is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC), to provide continuing education for the healthcare team.
Accreditation Council for Continuing Medical Education
Accreditation Council for Pharmacy Education
Florida Board of Pharmacy
Florida Board of Pharmacy (CEBroker Provider #50-290)
Course Delivery Method and Format: